Seizert Capital Partners, LLC Pfizer Inc Transaction History

Seizert Capital Partners, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	SELL	$41.75 - $54.5 $7,723 - $10,082	-185 Reduced 3.51%	5,090 $260,000
Q2 2022 Aug 04, 2022	SELL	$46.53 - $55.17 $4,792 - $5,682	-103 Reduced 1.92%	5,275 $277,000
Q1 2022 May 03, 2022	BUY	$45.75 - $56.69 $29,508 - $36,565	645 Added 13.63%	5,378 $278,000
Q4 2021 Feb 08, 2022	BUY	$41.32 - $61.25 $195,567 - $289,896	4,733 New	4,733 $279,000
Q1 2020 May 05, 2020	SELL	$27.03 - $38.62 $636,232 - $909,037	-23,538 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$32.92 - $37.36 $35,454 - $40,236	-1,077 Reduced 4.38%	23,538 $922,000
Q3 2019 Nov 07, 2019	SELL	$32.49 - $42.13 $45,453 - $58,939	-1,399 Reduced 5.38%	24,615 $884,000
Q2 2019 Aug 06, 2019	SELL	$36.98 - $41.52 $786,009 - $882,507	-21,255 Reduced 44.97%	26,014 $1.13 Million
Q1 2019 May 07, 2019	SELL	$37.5 - $41.2 $12.1 Million - $13.2 Million	-321,435 Reduced 87.18%	47,269 $2.01 Million
Q4 2018 Feb 08, 2019	SELL	$38.47 - $43.86 $1.22 Million - $1.39 Million	-31,735 Reduced 7.93%	368,704 $16.1 Million
Q3 2018 Nov 09, 2018	SELL	$34.47 - $41.81 $1.41 Million - $1.71 Million	-40,833 Reduced 9.25%	400,439 $17.6 Million
Q1 2018 May 10, 2018	SELL	$31.91 - $37.02 $219,540 - $254,697	-6,880 Reduced 1.54%	441,272 $15.7 Million
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $537,215 - $570,004	16,152 Added 3.74%	448,152 $16.2 Million
Q3 2017 Oct 31, 2017	SELL	$31.0 - $34.15 $1.59 Million - $1.75 Million	-51,300 Reduced 10.61%	432,000 $15.4 Million
Q2 2017 Aug 09, 2017	BUY	N/A	483,300	483,300 $16.2 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Seizert Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Seizert Capital Partners, LLC with notifications on news.